Vanda Pharmaceuticals (VNDA) Price Target: AI vs Analyst Consensus
Our AI model gives Vanda Pharmaceuticals (VNDA) a 6-month price target of $4.59, representing 8.4% potential downside from the current price of $5.01. The forecast combines financial fundamentals, technical analysis, and 25+ alternative data signals, including hiring trends, web traffic, employee sentiment, and social media activity. Vanda Pharmaceuticals’s current AI Score is 33/100 (Sell).
What’s Driving the VNDA Price Target
These are the signals feeding Vanda Pharmaceuticals’s AI price target — spanning financial fundamentals, technical analysis, and alternative data — grouped by their recent direction. Improving signals tend to support a higher target; declining signals weigh on it.
No signals trending up right now.
VNDA Stock Forecast for 2026
Our AI model gives Vanda Pharmaceuticals (VNDA) a 6-month price target of $4.59 — 8.4% downside from the current price of $5.01 — implying a decline toward that level through the rest of 2026. The target updates daily as new VNDA financial, technical, and alternative-data signals come in.
VNDA Price Prediction for 2027–2030
AltIndex does not publish a multi-year model — alternative data is most predictive over the next 6–12 months. Extending the current trajectory as a simple linear extrapolation projects VNDA toward $2.21 by 2030, but long-range estimates carry far more uncertainty and should be treated as directional only. The more reliable signal is whether Vanda Pharmaceuticals’s AI Score and the drivers above keep improving over time.
Vanda Pharmaceuticals (VNDA) Monthly Price Forecast
| Month | Forecast | vs Current |
|---|---|---|
| Oct 2026 | $4.94 | -1.4% |
| Nov 2026 | $4.87 | -2.8% |
| Dec 2026 | $4.80 | -4.2% |
| Jan 2027 | $4.73 | -5.6% |
| Feb 2027 | $4.66 | -7% |
| Mar 2027 | $4.59 | -8.4% |
Straight-line projection from the latest price ($5.01) toward our 6-month AI target of $4.59. An estimate, not a month-by-month model.
See how AltIndex’s AI Score picks have performed →Similar companies
View All →
Frequently Asked Questions: Vanda Pharmaceuticals Price Prediction
On September 12, Vanda Pharmaceuticals (VNDA) was assigned a Sell signal with a target price of $4.59. This signal was predicated on several factors, including concerns regarding the company's financial fundamentals, a long-term decrease in job posts, and a month-over-month drop in business outlook across the company's employees.
The conviction in the pick is medium-low due to the fairly restrained amount of alternative data available.
Based on Alternative Data, Vanda Pharmaceuticals is a sell.
Based on our Alternative data analysis, it's advisable to consider selling Vanda Pharmaceuticals (VNDA) stock. The observed negative trends all contribute to a sell signal. However, this information should not be considered financial advice. Like any investment choice, it's important to conduct comprehensive research, not only utilizing alternative data, but also considering the company's financials, industry trends, and recent news developments.
With an AI score of 33, the VNDA stock forecast indicates a potential decline.
To predict the price for VNDA in 2027, we can extrapolate the AI price target. This approach projects VNDA's price to reach $4.73.
To predict the price for VNDA in 2030, we can again extrapolate the AI price target. This approach projects VNDA's price to reach $2.21.
When predicting the price for VNDA, our approach incorporates multiple scores assessing different aspects of the company. The Brand score measures growth and engagement across social media channels, indicating audience reach. The Employee score evaluates workforce health, considering job postings, business outlook, and employee ratings. The Customer score examines engagement on websites, app downloads, and sentiment in stock forums. Lastly, the Fundamental score analyzes financial statements and analyst ratings. By evaluating this data, we gain a holistic view of the company's performance, enabling more informed price predictions.
Based on technical analysis of how the price has moved over the last 6 months, the likelihood of the price going up tomorrow is 41%. Note that this is a simplistic analysis and should be used with caution, as prices are influenced by a myriad of factors.
Know the moment Vanda Pharmaceuticals’s price target changes
Get VNDA alerts
